P53 functional mutation type in high-grade serous ovarian cancer and clinical outcomes.

被引：0
|
作者：
Mandilaras, Victoria
Garg, Swati
Burnier, Julia
Karakasis, Katherine
Wang, Lisa
Mackay, Helen
Dhani, Neesha C.
Butler, Marcus O.
Rodriguez-Freixinos, Victor
Wilson, Michelle K.
Martin-Lorente, Cristina
Ethier, Josee-Lyne
Bedard, Philippe L.
Siu, Lillian L.
Clarke, Blaise
Shaw, Patricia Ann
Stockley, Tracy
Oza, Amit M.
Lheureux, Stephanie
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Hlth Network, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Biostatist, Toronto, ON, Canada
[6] Univ Toronto, Toronto, ON, Canada
[7] Univ Hlth Network, Dept Pathol & Lab Med, Toronto, ON, Canada
[8] Univ Hlth Network, Lab Med Program, Genome Diagnost, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5550
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Correlation of p53 Immunohistochemical Expression with TP53 Mutation in Extrauterine High-Grade Serous Carcinoma
    Karim, Lina Abdul
    Yang, Richard
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 639 - 640
  • [22] Immunoexpression of p53 and p16 in Low and High-grade Serous Ovarian Cancer: A Cross-sectional Study
    Mandal, Ranajit
    Mondal, Rajib Kumar
    Rakshit, Sarbari Kar
    Roy, Anup Kumar
    Hazra, Rathin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (11) : EC18 - EC22
  • [23] Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing
    Cole, Alexander J.
    Dwight, Trisha
    Gill, Anthony J.
    Dickson, Kristie-Ann
    Zhu, Ying
    Clarkson, Adele
    Gard, Gregory B.
    Maidens, Jayne
    Valmadre, Susan
    Clifton-Bligh, Roderick
    Marsh, Deborah J.
    SCIENTIFIC REPORTS, 2016, 6
  • [24] Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing
    Alexander J. Cole
    Trisha Dwight
    Anthony J. Gill
    Kristie-Ann Dickson
    Ying Zhu
    Adele Clarkson
    Gregory B. Gard
    Jayne Maidens
    Susan Valmadre
    Roderick Clifton-Bligh
    Deborah J. Marsh
    Scientific Reports, 6
  • [25] Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in BRCA/P53 models
    Wyant, Gregory A.
    Perets, Ruth
    Muto, Katherine
    Poole, Barish B.
    Chen, Jin Y. H.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [26] Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer
    Raab, Monika
    Kostova, Izabela
    Pena-Llopis, Samuel
    Fietz, Daniela
    Kressin, Monika
    Aberoumandi, Seyed Mohsen
    Ullrich, Evelyn
    Becker, Sven
    Sanhaji, Mourad
    Strebhardt, Klaus
    CANCER COMMUNICATIONS, 2024, 44 (01) : 101 - 126
  • [27] Microenvironment cell populations are associated with clinical outcomes in high-grade serous ovarian cancer
    Watson, Rachel
    Linder, Katharine
    Gabrilovich, Sofia
    Ulmer, Keely
    Polio, Andrew
    Goodheart, Michael
    Bender, David
    Bosquet, Jesus Gonzalez
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S196 - S196
  • [28] Association of fusion genes with clinical outcomes and survival in high-grade serous ovarian cancer
    Newtson, A. M.
    Reyes, H. D.
    Lyons, Y. A.
    Cardillo, N. D.
    Russo, D.
    Devor, E.
    Goodheart, M. J.
    Gonzalez-Bosquet, J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 103 - 104
  • [29] High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes
    Nougaret, Stephanie
    Lakhman, Yulia
    Gonen, Mithat
    Goldman, Debra A.
    Micco, Maura
    D'Anastasi, Melvin
    Johnson, Sarah A.
    Juluru, Krishna
    Arnold, Angela G.
    Sosa, Ramon E.
    Soslow, Robert A.
    Vargas, Hebert Alberto
    Hricak, Hedvig
    Kauff, Noah D.
    Sala, Evis
    RADIOLOGY, 2017, 285 (02) : 472 - 481
  • [30] Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer
    Qu, Hui
    Xia, Yu
    Li, Xiuqin
    CURRENT GENE THERAPY, 2020, 20 (04) : 313 - 320
12345